Joseph Carroll
Comptroller/Controller/Auditor chez RENOVACOR, INC.
Postes actifs de Joseph Carroll
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| RENOVACOR, INC. | Comptroller/Controller/Auditor | 17/06/2022 | - |
| Secrétaire Général | 17/06/2022 | - | |
| Corporate Officer/Principal | 01/06/2021 | 17/06/2022 |
Historique de carrière de Joseph Carroll
Anciens postes connus de Joseph Carroll
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Corporate Officer/Principal | 01/06/2017 | 01/06/2021 |
Formation de Joseph Carroll
| West Chester University of Pennsylvania | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Comptroller/Controller/Auditor | 1 |
| Corporate Secretary | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Renovacor, Inc.
 Renovacor, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a clinical stage gene therapy company. It researches and develops AAV-based gene therapies for BAG3 gene mutation-associated diseases. Its therapeutic focus is on cardiovascular diseases. The company was founded by Arthur Michael Feldman on June 7, 2013 and is headquartered in Cambridge, MA. | Health Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Health Technology |
- Bourse
- Insiders
- Joseph Carroll
- Expérience
